G943-0313 Screening compound: N~2~-(2-methyl-1-{[(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)amino]carbonyl}propyl)-2-furamide

G943-0313 Screening compound: N~2~-(2-methyl-1-{[(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)amino]carbonyl}propyl)-2-furamide
G943-0313 Screening compound: N~2~-(2-methyl-1-{[(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)amino]carbonyl}propyl)-2-furamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G943-0313
N~2~-(2-methyl-1-{[(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)amino]carbonyl}propyl)-2-furamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G943-0313

Molecular Formula

C26H27N3O4S (C26 H27 N3 O4 S)

Compound Name

N~2~-(2-methyl-1-{[(11-oxo-10-propyl-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)amino]carbonyl}propyl)-2-furamide

IUPAC name

2-[(furan-2-yl)formamido]-3-methyl-N-{10-oxo-9-propyl-2-thia-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)3571214-hexaen-5-yl}butanamide

SMILES

CCCN(c(ccc(NC(C(C(C)C)NC(c1ccco1)=O)=O)c1)c1Sc1c2cccc1)C2=O

InChI

InChI=1S/C26H27N3O4S/c1-4-13-29-19-12-11-17(15-22(19)34-21-10-6-5-8-18(21)26(29)32)27-25(31)23(16(2)3)28-24(30)20-9-7-14-33-20/h5-12,14-16,23H,4,13H2,1-3H3,(H,27,31)(H,28,30)/t23-/m0/s1

InChI Key

QIENIJNRPIPFIP-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD27168937

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.932

Distribution Coefficient, logD

4.932

Water Solubility, LogSw

-4.40

Polar Surface Area

71.357

Acid Dissociation Constant (pKa)

13.01

Base Dissociation Constant (pKb)

-1.27

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.90

G943-0313 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

SH2 Library (10483 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Endocrine
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G943-0313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G943-0313?
Check Price and Availability of G943-0313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G943-0313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G943-0313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G943-0313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G943-0313 available by request